Compare COUR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COUR | SLNO |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 2.5B |
| IPO Year | 2021 | 2014 |
| Metric | COUR | SLNO |
|---|---|---|
| Price | $7.45 | $47.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 10 |
| Target Price | $12.33 | ★ $110.90 |
| AVG Volume (30 Days) | ★ 4.0M | 1.3M |
| Earning Date | 01-29-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $739,774,000.00 | $98,675,000.00 |
| Revenue This Year | $10.46 | N/A |
| Revenue Next Year | $6.00 | $155.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 8.09 | N/A |
| 52 Week Low | $5.76 | $41.50 |
| 52 Week High | $13.56 | $90.32 |
| Indicator | COUR | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 35.67 | 42.01 |
| Support Level | $7.33 | $47.01 |
| Resistance Level | $8.89 | $49.75 |
| Average True Range (ATR) | 0.37 | 2.37 |
| MACD | -0.03 | 0.12 |
| Stochastic Oscillator | 8.31 | 8.91 |
Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.